These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21353541)

  • 1. Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β3 adrenergic receptor agonists.
    Morriello GJ; Wendt HR; Bansal A; Di Salvo J; Feighner S; He J; Hurley AL; Hreniuk DL; Salituro GM; Reddy MV; Galloway SM; McGettigan KK; Laws G; McKnight C; Doss GA; Tsou NN; Black RM; Morris J; Ball RG; Sanfiz AT; Streckfuss E; Struthers M; Edmondson SD
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1865-70. PubMed ID: 21353541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
    Imanishi M; Tomishima Y; Itou S; Hamashima H; Nakajima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
    J Med Chem; 2008 Mar; 51(6):1925-44. PubMed ID: 18307290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist.
    Nakajima Y; Hamashima H; Washizuka K; Tomishima Y; Ohtake H; Imamura E; Miura T; Kayakiri H; Kato M
    Bioorg Med Chem Lett; 2005 Jan; 15(2):251-4. PubMed ID: 15603933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6.
    Hattori K; Orita M; Toda S; Imanishi M; Itou S; Nakajima Y; Tanabe D; Washizuka K; Araki T; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4679-83. PubMed ID: 19608416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 1,7-cyclized indoles as a new class of potent and highly selective human beta3-adrenergic receptor agonists with high cell permeability.
    Mizuno K; Sawa M; Harada H; Taoka I; Yamashita H; Oue M; Tsujiuchi H; Arai Y; Suzuki S; Furutani Y; Kato S
    Bioorg Med Chem; 2005 Feb; 13(3):855-68. PubMed ID: 15653351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel acetanilide derivatives as potent and selective beta3-adrenergic receptor agonists.
    Maruyama T; Onda K; Hayakawa M; Matsui T; Takasu T; Ohta M
    Eur J Med Chem; 2009 Jun; 44(6):2533-43. PubMed ID: 19232786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.
    Zheng W; Nikulin VI; Konkar AA; Vansal SS; Shams G; Feller DR; Miller DD
    J Med Chem; 1999 Jun; 42(12):2287-94. PubMed ID: 10377236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
    Tanaka N; Tamai T; Mukaiyama H; Hirabayashi A; Muranaka H; Ishikawa T; Kobayashi J; Akahane S; Akahane M
    J Med Chem; 2003 Jan; 46(1):105-12. PubMed ID: 12502364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity.
    Lafontaine JA; Day RF; Dibrino J; Hadcock JR; Hargrove DM; Linhares M; Martin KA; Maurer TS; Nardone NA; Tess DA; Dasilva-Jardine P
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5245-50. PubMed ID: 17632003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptamine-based human beta3-adrenergic receptor agonists. Part 2: SAR of the methylene derivatives.
    Sawa M; Tateishi H; Mizuno K; Harada H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5963-6. PubMed ID: 15546708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring.
    Mizuno K; Sawa M; Harada H; Tateishi H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5959-62. PubMed ID: 15546707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
    Nakajima Y; Imanishi M; Itou S; Hamashima H; Tomishima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Hattori K
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5037-40. PubMed ID: 18752946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: part 5.
    Hattori K; Toda S; Imanishi M; Itou S; Nakajima Y; Washizuka K; Araki T; Hamashima H; Tomishima Y; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
    J Med Chem; 2009 May; 52(9):3063-72. PubMed ID: 19366244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and selective, sulfamide-based human beta 3-adrenergic receptor agonists.
    Dow RL; Paight ES; Schneider SR; Hadcock JR; Hargrove DM; Martin KA; Maurer TS; Nardone NA; Tess DA; DaSilva-Jardine P
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3235-40. PubMed ID: 15149682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist interactions with chimeric and mutant beta1- and beta3-adrenergic receptors: involvement of the seventh transmembrane region in conferring subtype specificity.
    Granneman JG; Lahners KN; Zhai Y
    Mol Pharmacol; 1998 May; 53(5):856-61. PubMed ID: 9584211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations.
    Washburn WN; Harper TW; Wu G; Godfrey JD; McCann P; Girotra R; Shao C; Zhang H; Gavai A; Mikkilineni A; Dejneka T; Ahmed S; Caringal Y; Hangeland J; Zhang M; Cheng PT; Russell AD; Skwish S; Slusarchyk DA; Allen GT; Frohlich BH; Abboa-Offei BE; Cap M; Waldron TL; George RJ; Tesfamariam B; Dickinson KE; Seymour AA; Sher PM
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4290-6. PubMed ID: 17533126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
    J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
    Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
    J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists.
    Parmee ER; Brockunier LL; He J; Singh SB; Candelore MR; Cascieri MA; Deng L; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2283-6. PubMed ID: 11055339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective beta3-adrenergic receptor agonists.
    Maruyama T; Onda K; Hayakawa M; Seki N; Takahashi T; Moritomo H; Suzuki T; Matsui T; Takasu T; Nagase I; Ohta M
    Bioorg Med Chem; 2009 May; 17(9):3283-94. PubMed ID: 19362005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.